Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affairs Canada for Reactivation Program
March 3, 2022
Cognetivity Neurosciences Closes Final Tranche of Unit Offering
February 25, 2022
Silo Wellness Announces Successful Launch of 2022 Psilocybin Retreat Schedule and other Corporate Updates
February 23, 2022
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
February 17, 2022
Neuroplasticity, Psychedelics, and Mental Health
February 17, 2022
Zollaris Laboratories Corp. Receives Health Canada authorization to investigate PSILOCYBIN (PSYCHEDELIC MUSHROOMS) for potential new therapeutics
February 16, 2022
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
February 16, 2022